STOCK TITAN

[8-K] Corebridge Financial, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Corebridge Financial disclosed that American International Group, Inc. (the Selling Stockholder) entered into an underwriting agreement with Morgan Stanley & Co. LLC under which the Selling Stockholder agreed to sell 30,000,000 shares of Corebridge common stock at $33.5113 per share. The Underwriter was granted a 30-day option to purchase up to an additional 4,500,000 shares to cover over-allotments. The filing attaches the Underwriting Agreement as Exhibit 1.1 and a legal opinion from Debevoise & Plimpton LLP as Exhibit 5.1, with Debevoise's consent in Exhibit 23.1.

The disclosure describes the transaction terms and supporting exhibits but does not provide details about use of proceeds, the effect on outstanding shares or public float, or any company action beyond furnishing the agreement and opinion.

Corebridge Financial ha comunicato che American International Group, Inc. (l'azionista venditore) ha stipulato un accordo di collocamento con Morgan Stanley & Co. LLC in base al quale l'azionista venditore ha concordato di vendere 30,000,000 azioni ordinarie di Corebridge al prezzo di $33.5113 per azione. Al sottoscrittore è stata concessa un'opzione di 30 giorni per acquistare fino ad ulteriori 4,500,000 azioni per coprire eventuali sovrallocazioni. Il deposito allega l'Underwriting Agreement come Exhibit 1.1 e un parere legale di Debevoise & Plimpton LLP come Exhibit 5.1, con il consenso di Debevoise indicato in Exhibit 23.1.

La comunicazione descrive i termini dell'operazione e gli exhibit a supporto, ma non fornisce dettagli sull'uso dei proventi, sull'effetto sulle azioni in circolazione o sul flottante, né su eventuali azioni societarie oltre alla mera messa a disposizione dell'accordo e del parere legale.

Corebridge Financial divulgó que American International Group, Inc. (el accionista vendedor) suscribió un acuerdo de colocación con Morgan Stanley & Co. LLC, en virtud del cual el accionista vendedor acordó vender 30,000,000 acciones ordinarias de Corebridge a $33.5113 por acción. Al suscriptor se le otorgó una opción de 30 días para comprar hasta 4,500,000 acciones adicionales para cubrir sobresuscripciones. La presentación adjunta el Underwriting Agreement como Exhibit 1.1 y una opinión legal de Debevoise & Plimpton LLP como Exhibit 5.1, con el consentimiento de Debevoise en el Exhibit 23.1.

La divulgación describe los términos de la transacción y los documentos de apoyo, pero no proporciona detalles sobre el uso de los ingresos, el efecto sobre las acciones en circulación o el flotante, ni acerca de cualquier acción de la compañía más allá de facilitar el acuerdo y la opinión legal.

Corebridge Financial은 American International Group, Inc.(매도 주주)가 Morgan Stanley & Co. LLC와 인수계약을 체결했으며, 그에 따라 매도 주주는 Corebridge 보통주 30,000,000주를 주당 $33.5113에 매각하기로 합의했다고 공시했습니다. 인수인에게는 초과배정분을 충당하기 위해 최대 추가 4,500,000주를 매수할 수 있는 30일 옵션이 부여되었습니다. 제출서류에는 인수계약서(Exhibit 1.1)와 Debevoise & Plimpton LLP의 법률의견서(Exhibit 5.1)가 첨부되어 있으며, Debevoise의 동의는 Exhibit 23.1에 포함되어 있습니다.

공시는 거래 조건과 관련 첨부문서를 설명하고 있으나, 수익금 사용처, 발행주식수나 유통주식수에 미치는 영향, 또는 계약 및 법률의견서 제공 외에 회사가 취할 조치에 대해서는 구체적으로 언급하지 않습니다.

Corebridge Financial a annoncé qu'American International Group, Inc. (l'actionnaire vendeur) a conclu un contrat de souscription avec Morgan Stanley & Co. LLC en vertu duquel l'actionnaire vendeur a accepté de vendre 30,000,000 actions ordinaires de Corebridge au prix de $33.5113 par action. Le souscripteur s'est vu accorder une option de 30 jours pour acheter jusqu'à 4,500,000 actions supplémentaires afin de couvrir les surallocations. Le dépôt joint le contrat de souscription en tant qu'Exhibit 1.1 et un avis juridique de Debevoise & Plimpton LLP en tant qu'Exhibit 5.1, le consentement de Debevoise figurant en Exhibit 23.1.

La communication décrit les termes de la transaction et les annexes justificatives, mais ne fournit pas de précisions sur l'utilisation des produits, l'effet sur les actions en circulation ou le flottant, ni sur d'éventuelles mesures de la société au-delà de la simple mise à disposition du contrat et de l'avis juridique.

Corebridge Financial gab bekannt, dass American International Group, Inc. (der veräußernde Aktionär) einen Zeichnungsvertrag mit Morgan Stanley & Co. LLC abgeschlossen hat, wonach der veräußernde Aktionär zustimmte, 30,000,000 Stammaktien von Corebridge zu einem Preis von $33.5113 je Aktie zu veräußern. Dem Zeichner wurde eine 30-tägige Option eingeräumt, bis zu weitere 4,500,000 Aktien zu erwerben, um Überzuteilungen abzudecken. Die Einreichung fügt den Zeichnungsvertrag als Exhibit 1.1 sowie ein Rechtsgutachten von Debevoise & Plimpton LLP als Exhibit 5.1 bei; die Zustimmung von Debevoise ist in Exhibit 23.1 enthalten.

Die Bekanntgabe erläutert die Transaktionsbedingungen und die beigefügten Unterlagen, enthält jedoch keine Angaben zur Verwendung des Erlöses, zur Auswirkung auf ausstehende Aktien oder den Streubesitz und auch nicht zu sonstigen Maßnahmen des Unternehmens über die Bereitstellung des Vertrags und des Rechtsgutachtens hinaus.

Positive
  • Underwritten transaction executed with Morgan Stanley & Co. LLC, establishing an orderly sale mechanism.
  • Defined pricing at $33.5113 per share for the offered 30,000,000 shares.
  • Standard over-allotment option granted for up to 4,500,000 additional shares to cover demand.
  • Supporting exhibits filed including the Underwriting Agreement (Exhibit 1.1) and legal opinion (Exhibit 5.1).
Negative
  • Large block sale of 30,000,000 shares by the Selling Stockholder (AIG) is being offered in the market.
  • Filing lacks details on the timing of share distribution and the intended use of proceeds, if any.
  • No disclosure in this document of the effect on total outstanding shares or public float post-transaction.
  • Limited transaction detail beyond the agreement summary; the description is qualified by the exhibit and may require review of Exhibit 1.1 for complete terms.

Insights

TL;DR: AIG will sell 30 million CRBG shares at a fixed price via an underwritten placement with a 4.5 million over-allotment option.

The filing documents a secondary, underwritten sale where the Selling Stockholder (AIG) sets the offer size and price at $33.5113 per share and Morgan Stanley acts as underwriter. The presence of a standard 30-day over-allotment option suggests the transaction follows market practice to stabilize distribution. The filing includes the underwriting agreement and a legal opinion, but it does not disclose details on how the sale will affect public float, outstanding shares, or timing of distribution; those are material for market impact analysis.

TL;DR: This is a disclosed, underwritten secondary sale by a principal shareholder; governance implications are limited to ownership change disclosure.

The 8-K reports a transparent, underwritten process for a large block sale by the Selling Stockholder, with required exhibits including counsel opinion and consent. From a governance perspective, the filing shows compliance with disclosure norms for a material stock disposition by a major holder. The document does not, however, provide information on post-transaction ownership percentages, any agreements governing the sale beyond the underwriting agreement, or whether the company facilitated registration — items investors often need to assess ownership and control changes.

Corebridge Financial ha comunicato che American International Group, Inc. (l'azionista venditore) ha stipulato un accordo di collocamento con Morgan Stanley & Co. LLC in base al quale l'azionista venditore ha concordato di vendere 30,000,000 azioni ordinarie di Corebridge al prezzo di $33.5113 per azione. Al sottoscrittore è stata concessa un'opzione di 30 giorni per acquistare fino ad ulteriori 4,500,000 azioni per coprire eventuali sovrallocazioni. Il deposito allega l'Underwriting Agreement come Exhibit 1.1 e un parere legale di Debevoise & Plimpton LLP come Exhibit 5.1, con il consenso di Debevoise indicato in Exhibit 23.1.

La comunicazione descrive i termini dell'operazione e gli exhibit a supporto, ma non fornisce dettagli sull'uso dei proventi, sull'effetto sulle azioni in circolazione o sul flottante, né su eventuali azioni societarie oltre alla mera messa a disposizione dell'accordo e del parere legale.

Corebridge Financial divulgó que American International Group, Inc. (el accionista vendedor) suscribió un acuerdo de colocación con Morgan Stanley & Co. LLC, en virtud del cual el accionista vendedor acordó vender 30,000,000 acciones ordinarias de Corebridge a $33.5113 por acción. Al suscriptor se le otorgó una opción de 30 días para comprar hasta 4,500,000 acciones adicionales para cubrir sobresuscripciones. La presentación adjunta el Underwriting Agreement como Exhibit 1.1 y una opinión legal de Debevoise & Plimpton LLP como Exhibit 5.1, con el consentimiento de Debevoise en el Exhibit 23.1.

La divulgación describe los términos de la transacción y los documentos de apoyo, pero no proporciona detalles sobre el uso de los ingresos, el efecto sobre las acciones en circulación o el flotante, ni acerca de cualquier acción de la compañía más allá de facilitar el acuerdo y la opinión legal.

Corebridge Financial은 American International Group, Inc.(매도 주주)가 Morgan Stanley & Co. LLC와 인수계약을 체결했으며, 그에 따라 매도 주주는 Corebridge 보통주 30,000,000주를 주당 $33.5113에 매각하기로 합의했다고 공시했습니다. 인수인에게는 초과배정분을 충당하기 위해 최대 추가 4,500,000주를 매수할 수 있는 30일 옵션이 부여되었습니다. 제출서류에는 인수계약서(Exhibit 1.1)와 Debevoise & Plimpton LLP의 법률의견서(Exhibit 5.1)가 첨부되어 있으며, Debevoise의 동의는 Exhibit 23.1에 포함되어 있습니다.

공시는 거래 조건과 관련 첨부문서를 설명하고 있으나, 수익금 사용처, 발행주식수나 유통주식수에 미치는 영향, 또는 계약 및 법률의견서 제공 외에 회사가 취할 조치에 대해서는 구체적으로 언급하지 않습니다.

Corebridge Financial a annoncé qu'American International Group, Inc. (l'actionnaire vendeur) a conclu un contrat de souscription avec Morgan Stanley & Co. LLC en vertu duquel l'actionnaire vendeur a accepté de vendre 30,000,000 actions ordinaires de Corebridge au prix de $33.5113 par action. Le souscripteur s'est vu accorder une option de 30 jours pour acheter jusqu'à 4,500,000 actions supplémentaires afin de couvrir les surallocations. Le dépôt joint le contrat de souscription en tant qu'Exhibit 1.1 et un avis juridique de Debevoise & Plimpton LLP en tant qu'Exhibit 5.1, le consentement de Debevoise figurant en Exhibit 23.1.

La communication décrit les termes de la transaction et les annexes justificatives, mais ne fournit pas de précisions sur l'utilisation des produits, l'effet sur les actions en circulation ou le flottant, ni sur d'éventuelles mesures de la société au-delà de la simple mise à disposition du contrat et de l'avis juridique.

Corebridge Financial gab bekannt, dass American International Group, Inc. (der veräußernde Aktionär) einen Zeichnungsvertrag mit Morgan Stanley & Co. LLC abgeschlossen hat, wonach der veräußernde Aktionär zustimmte, 30,000,000 Stammaktien von Corebridge zu einem Preis von $33.5113 je Aktie zu veräußern. Dem Zeichner wurde eine 30-tägige Option eingeräumt, bis zu weitere 4,500,000 Aktien zu erwerben, um Überzuteilungen abzudecken. Die Einreichung fügt den Zeichnungsvertrag als Exhibit 1.1 sowie ein Rechtsgutachten von Debevoise & Plimpton LLP als Exhibit 5.1 bei; die Zustimmung von Debevoise ist in Exhibit 23.1 enthalten.

Die Bekanntgabe erläutert die Transaktionsbedingungen und die beigefügten Unterlagen, enthält jedoch keine Angaben zur Verwendung des Erlöses, zur Auswirkung auf ausstehende Aktien oder den Streubesitz und auch nicht zu sonstigen Maßnahmen des Unternehmens über die Bereitstellung des Vertrags und des Rechtsgutachtens hinaus.

0001889539FALSE00018895392025-08-062025-08-060001889539us-gaap:CommonStockMember2025-08-062025-08-060001889539crbg:A6.375JuniorSubordinatedNotesDue2064Member2025-08-062025-08-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 8, 2025
(August 6, 2025)
Corebridge Financial, Inc.
(Exact name of registrant as specified in its charter)
Delaware001-4150495-4715639
(State or Other Jurisdiction(Commission (IRS Employer
of Incorporation)File Number)Identification No.)
2919 Allen Parkway, Woodson Tower,
Houston,Texas77019
(Address of Principal Executive Offices)(Zip Code)
1-877-375-2422
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common StockCRBGNew York Stock Exchange
6.375% Junior Subordinated NotesCRBDNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 8.01    Other Events
Underwriting Agreement
On August 6, 2025, Corebridge Financial, Inc. (the “Company”), American International Group, Inc. (the “Selling Stockholder”), and Morgan Stanley & Co. LLC (the “Underwriter”) entered into an underwriting agreement (the “Underwriting Agreement”) pursuant to which the Selling Stockholder agreed to sell to the Underwriter, and the Underwriter agreed to purchase from the Selling Stockholder, subject to and upon the terms and conditions set forth therein, 30,000,000 shares of the Company’s common stock, par value $0.01 per share (“Common Stock”), at a price of $33.5113 per share. The Selling Stockholder also granted the Underwriters a 30-day option to purchase up to an additional 4,500,000 shares of Common Stock solely to cover over-allotments.
The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to the copy thereof, which is filed herewith as Exhibit 1.1 and is incorporated herein by reference. The opinion of Debevoise & Plimpton LLP, relating to the validity of the Common Stock, is filed as Exhibit 5.1 hereto.
Item 9.01    Financial Statements and Exhibits
(d)    Exhibits.
Exhibit Number        Description
Exhibit NumberDescription
1.1
Underwriting Agreement, dated August 6, 2025, between Corebridge Financial, Inc., American International Group, Inc., and Morgan Stanley & Co. LLC. (redacted)
5.1
Opinion of Debevoise & Plimpton LLP.
23.1
Consent of Debevoise & Plimpton LLP (contained in Exhibit 5.1).
104Cover Page Interactive Data File (embedded within the Inline XBRL document).



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 8, 2025Corebridge Financial, Inc.
By:/s/ Elias Habayeb
Name: Elias Habayeb
Title: Chief Financial Officer
[Signature Page to Form 8-K]

FAQ

What did Corebridge (CRBG) disclose in this 8-K?

Corebridge disclosed that the Selling Stockholder, American International Group, Inc., entered into an underwriting agreement to sell common stock through Morgan Stanley.

How many Corebridge (CRBG) shares are being sold and at what price?

The agreement covers 30,000,000 shares at $33.5113 per share, with an underwriter option for up to 4,500,000 additional shares.

Who is the selling stockholder and who is the underwriter for the CRBG offering?

The Selling Stockholder is American International Group, Inc. (AIG) and the underwriter is Morgan Stanley & Co. LLC.

Is there an over-allotment (greenshoe) option in the transaction?

Yes. The underwriters were granted a 30-day option to purchase up to 4,500,000 additional shares to cover over-allotments.

Where can I find the full underwriting agreement and legal opinions?

The filing references the Underwriting Agreement as Exhibit 1.1, the legal opinion of Debevoise & Plimpton LLP as Exhibit 5.1, and consent in Exhibit 23.1.
Corebridge Financial Inc

NYSE:CRBG

CRBG Rankings

CRBG Latest News

CRBG Latest SEC Filings

CRBG Stock Data

18.44B
485.76M
0.31%
106.27%
1.04%
Asset Management
Life Insurance
Link
United States
HOUSTON